Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXY5PQ
|
||||
Drug Name |
[1-{[1-(1,3-benzodioxole-5-ylmethyl)-1H-imidazole-5-yl]methyl}-4-(1-naphthyl)-1H-pyrrole-3yl](4-methyl-1-piperazinyl)methanone
|
||||
Synonyms |
CHEMBL105592
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C32H31N5O3
|
||||
Canonical SMILES |
CN1CCN(CC1)C(=O)c2cn(Cc3cncn3Cc4ccc5OCOc5c4)cc2c6cccc7ccccc67
|
||||
InChI |
InChI=1S/C32H31N5O3/c1-34-11-13-36(14-12-34)32(38)29-20-35(19-28(29)27-8-4-6-24-5-2-3-7-26(24)27)18-25-16-33-21-37(25)17-23-9-10-30-31(15-23)40-22-39-30/h2-10,15-16,19-21H,11-14,17-18,22H2,1H3
|
||||
InChIKey |
HWLBLFBLGGVDBT-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.